SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026

Impact · against what's priced in

The reminder of the lead plaintiff deadline for the securities class action is a procedural update that does not fundamentally change the risk profile of SPRY. The underlying catalysts—the lawsuit itself and the CVS Caremark coverage delay—were already reflected in the stock's June price collapse.

SPRY−0.10

No priced-in read yet